Spravato® (Esketamine)
70% Response
Relief in Days to Weeks
Safe & FDA-Approved
Covered by Insurance
Highlights
Effective
Spravato is among the most effective treatments available in psychiatry, with up to 69.3% response rates.
Safe
Spravato has gone through extensive clinical trials and is among the most rigorously studied mental health medications assessed for safety.
FDA Approved
The US FDA (and counterpart regulatory agencies in Europe and other countries) have approved Spravato, a testament to its safety and efficacy.
Covered by Insurance
Spravato is covered by most insurance providers (based on the diagnosis, prior treatment trials, and other factors), making Spravato an affordable treatment choice for many people.
*Please note that Rumi Mind Health may not have a contract with your insurance provider even if they do cover Spravato elsewhere.
To learn more, you can fill out the self-referral form below, or call/text us at 203-707-2000.
Providers can utilize the online referral system, or call us at 203-707-2000 to initiate a referral.
Treatment Overview
Once you are deemed eligible for the treatment, you will start a course of treatment that is typically twice a week for 4 weeks (a total of 8 treatments). After this course, based on your response and other factors, a decision will be made to either stop the treatment or to slowly taper it. In general, a tapering course consists of slowly going to once a week, then once every two weeks, and so on. While some patients need long-term treatment at various frequencies, many others are able to stop the treatment and maintain the gains for months or years afterwards.